Cav2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization

Cell Death Dis. 2022 Sep 22;13(9):812. doi: 10.1038/s41419-022-05174-0.

Abstract

Distant metastasis is the main cause of mortality in breast cancer patients. Using the breast cancer genomic data from The Cancer Genome Atlas (TCGA), we identified brain specific Cav2.2 as a critical regulator of metastasis. Cav2.2 expression is significantly upregulated in breast cancer and its higher expression is inversely correlated with survival suggesting a previously unappreciated role of Cav2.2 in breast cancer. Cav2.2 is required for breast cancer migration, invasion, and metastasis. Interestingly, Cav2.2 promotes invadopodia formation and extracellular matrix (ECM) degradation through the stabilization of invadopodia component cortactin in a proteosome-dependent manner. Moreover, deubiquitinating enzyme USP43 mediated the functions of Cav2.2 in cortactin stabilization, invadopodia formation, ECM degradation, and metastasis. Interestingly, Cav2.2 upregulates USP43 expression through NFAT2 dephosphorylation and nuclear localization. Our study uncovered a novel pathway that regulates cortactin expression and invadopodia formation in breast cancer metastasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms* / pathology
  • Calcium Channels, N-Type* / metabolism
  • Cell Line, Tumor
  • Cortactin / genetics
  • Cortactin / metabolism
  • Deubiquitinating Enzymes* / metabolism
  • Extracellular Matrix / metabolism
  • Female
  • Humans
  • NFATC Transcription Factors* / metabolism
  • Neoplasm Invasiveness
  • Podosomes* / metabolism

Substances

  • CACNA1B protein, human
  • Calcium Channels, N-Type
  • Cortactin
  • NFATC Transcription Factors
  • NFATC1 protein, human
  • Deubiquitinating Enzymes